Trexquant Investment LP Landec Corp \Ca\ Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	N/A	47,157 New	47,157 $0
Q1 2022 May 13, 2022	SELL	$10.07 - $11.93 $127,123 - $150,604	-12,624 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.95 - $11.24 $14,898 - $21,063	1,874 Added 17.43%	12,624 $140,000
Q3 2021 Nov 12, 2021	BUY	$9.22 - $12.44 $99,115 - $133,730	10,750 New	10,750 $99,000
Q2 2021 Aug 12, 2021	SELL	$9.91 - $12.78 $111,378 - $143,634	-11,239 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$10.44 - $12.22 $19,491 - $22,814	-1,867 Reduced 14.25%	11,239 $119,000
Q4 2020 Feb 11, 2021	BUY	$9.3 - $11.77 $121,885 - $154,257	13,106 New	13,106 $142,000

20.5M

65.8K

14.1K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.